Factors Associated With Hyperuricemia in Patients With Coronary Heart Disease
Reviews in Cardiovascular Medicine · 09.06.2026 · 27 (6)
DOI: 10.31083/rcm49042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 09.06.2026. Verfasst von Qinyu Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, 225001 Yangzhou, Jiangsu, China. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Postgraduate Research & Practice Innovation Program of Jiangsu Province.
Abstract (Originalsprache)
Background:This study aimed to investigate clinical factors associated with hyperuricemia (HUA) in patients with newly diagnosed coronary heart disease (CHD) and to evaluate the correlation of novel derived biomarkers with HUA, thereby providing a reference for clinical risk identification, prevention, and treatment.Methods:This retrospective study analyzed 2265 patients with newly diagnosed CHD (2019–2024) who were randomly assigned to a modeling group (n = 1812) and a validation group (n = 453); HUA was defined as serum uric acid (UA) ≥420 μmol/L. Least absolute shrinkage and selection operator (LASSO) regression and multivariate logistic regression were used to identify associated factors. A prediction model was constructed and evaluated using receiver operating characteristic (ROC) curves, decision curve analysis (DCA), and calibration plots.Results:Independent factors associated with HUA included triglycerides (odds ratio (OR) = 1.097, 95% CI: 1.036–1.160), creatinine (OR = 1.030, 95% CI: 1.025–1.035), monocyte-to-high-density lipoprotein cholesterol ratio (MHR; OR = 1.447, 95% CI: 1.057–1.981), remnant cholesterol (RC; OR = 1.812, 95% CI: 1.406–2.337), and alcohol use (OR = 1.596, 95% CI: 1.202–2.119) (all p < 0.05). The model demonstrated good discrimination with areas under the ROC curve (AUROCs) of 0.781 (0.729–0.832) in the modeling group and 0.780 (0.751–0.808) in the validation group, as well as good calibration and clinical utility at threshold probabilities of 0.22–1.00 and 0.20–0.66, respectively. MHR and RC exhibited a positive nonlinear relationship with HUA risk, with a stronger association for MHR in the hypertensive subgroup (p < 0.05).Conclusion:MHR and RC are novel biomarkers associated with HUA risk in patients with new-onset CHD. When combined with traditional factors such as triglycerides and creatinine, these novel biomarkers support a multifactorial, integrated evaluation of HUA-related risk and serve as a reference for clinical risk stratification and management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, 225001 Yangzhou, Jiangsu, China.
- Department of Cardiology, Northern Jiangsu People's Hospital, 225001 Yangzhou, Jiangsu, China.
- Department of Urology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, 225001 Yangzhou, Jiangsu, China.
- Department of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, 225000 Yangzhou, Jiangsu, China.
ORCID-Profile: Qinyu Sun, Wei Zhou, Jing Zhang
Förderung
- Postgraduate Research & Practice Innovation Program of Jiangsu Province
Zitieren
APA
Sun, Q., Deng, Y., Gao, Z., He, S., Zhou, W., & Zhang, J. (2026). Factors Associated With Hyperuricemia in Patients With Coronary Heart Disease. Reviews in Cardiovascular Medicine, 27(6). https://doi.org/10.31083/rcm49042
Vancouver
Sun Q, Deng Y, Gao Z, He S, Zhou W, Zhang J. Factors Associated With Hyperuricemia in Patients With Coronary Heart Disease. Reviews in Cardiovascular Medicine. 2026;27(6). doi:10.31083/rcm49042
BibTeX
@article{Sun2026,
author = {Sun, Qinyu and Deng, Yifan and Gao, Zhiyuan and He, Shenghu and Zhou, Wei and Zhang, Jing},
title = {Factors Associated With Hyperuricemia in Patients With Coronary Heart Disease},
journal = {Reviews in Cardiovascular Medicine},
year = {2026},
volume = {27},
number = {6},
doi = {10.31083/rcm49042}
}
EUVIMED